Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huixian Pharmaceutical
Kunshan, Jiangsu, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Huixian Pharmaceutical is a biotechnology company specializing in the discovery and development of innovative therapies using Targeted Protein Degradation (TPD) technology. Founded in 2018 and led by Dr. Jian Li, a former research executive at Novartis and GSK, the company utilizes its proprietary D-SMART platform to design and optimize Proteolysis Targeting Chimeras (PROTACs). Huixian Pharmaceutical focuses on addressing traditionally "undruggable" targets involved in the pathogenesis of cancer and autoimmune disorders. The company is backed by prominent investors including Baidu Ventures and CDIB Capital, and maintains research operations in Shanghai and Nanjing to advance its early-stage pipeline.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Small moleculePROTACTargeted protein degradation
- Industry
- Biotech
Beyond the preview
Go deeper on Huixian Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Huixian Pharmaceutical.